Imaging of matrix metalloproteinase activation and left ventricular remodeling

Grace Chung1, Albert J Sinusas

  • 1Yale University School of Medicine, Nuclear Cardiology, New Haven, CT 06520-8017, USA.

Insights

Matrix metalloproteinases (MMPs) drive pathological cardiac remodeling and poor heart function. Targeted MMP imaging, combined with physiologic assessments, shows promise for monitoring adverse left ventricular remodeling.

Area of Science:

  • Cardiovascular Science
  • Biochemistry
  • Medical Imaging

Background:

  • Left ventricular (LV) remodeling can be adaptive or pathological following cardiac injury.
  • Pathological LV remodeling is linked to poor prognosis and reduced cardiac function.
  • Matrix metalloproteinases (MMPs) degrade myocardial extracellular matrix and are implicated in adverse remodeling.

Purpose of the Study:

  • To explore the role of MMPs in cardiac remodeling.
  • To evaluate the potential of targeted MMP imaging for monitoring LV remodeling.
  • To assess the combination of MMP imaging with physiologic imaging.

Main Methods:

  • Review of existing literature on MMPs in cardiac remodeling (animal models and clinical studies).
  • Discussion of conventional imaging techniques for LV remodeling (perfusion, function).
  • Exploration of recent advancements in targeted MMP imaging.

Main Results:

  • MMPs play a significant role in the progression of adverse cardiac remodeling.
  • Targeted imaging of MMPs offers a novel approach to visualize this process.
  • Integrating MMP imaging with physiologic imaging may enhance monitoring capabilities.

Conclusions:

  • Continued left ventricular remodeling is a detrimental process.
  • Targeted MMP imaging presents a promising strategy for assessing cardiac remodeling.
  • Combined physiologic and MMP imaging could improve patient outcomes.